Drastic Reduction of Bacterial, Fungal and Viral Pathogen Titers by Cuprous Oxide Impregnated Medical Textiles
- PMID: 33535519
- PMCID: PMC7930948
- DOI: 10.3390/jfb12010009
Drastic Reduction of Bacterial, Fungal and Viral Pathogen Titers by Cuprous Oxide Impregnated Medical Textiles
Abstract
Hospital patients and personnel are at risk of nosocomial viral infections, as clearly manifested during the COVID-19 pandemic. Transmission of respiratory viral pathogens can occur through contaminated surfaces, including from medical textiles. Copper has potent biocidal properties, and cuprous oxide impregnated medical textiles (CMT) reduce hospital-acquired bacterial infections. In the current study we confirm the antimicrobial properties of CMT and determine their capacity to reduce infectious titres of human coronavirus (HCoV-229E) in an independent laboratory. The antibacterial and antiviral activities of the CMT were determined according to AATCC TM100-2019 and ISO 18184:2019 standards, respectively. The CMT reduced by 4 logs the viable titers of MRSA, Klebsiella pneumoniae, Enterococcus faecalis, and Candida auris after 2 h of incubation. Viable titers of Clostridium difficile were reduced by 2.3, 3, and 4 logs after 2, 6, and 18 h, respectively. Infectious titers of HCoV-229E exposed to CMT for 2 h were reduced by 2.8 and 4 logs (99.85% and 99.99% reductions) as compared to Time-0 control and initial inoculum, respectively. The CMT retain their antibacterial efficacy even after 100 industrial washings. Use of cuprous oxide impregnated textiles in clinical settings may reduce not only hospital acquired infections caused by bacterial and fungal pathogens, but also, and equally important, those caused by coronavirus and other viruses.
Keywords: coronavirus; cuprous oxide; hospital acquired infections; medical textiles; pathogens.
Conflict of interest statement
All authors are employees of Cupron Scientific or Cupron Inc., which produces cuprous oxide impregnated products.
Figures


Similar articles
-
Reduction of healthcare-associated infections in a long-term care brain injury ward by replacing regular linens with biocidal copper oxide impregnated linens.Int J Infect Dis. 2014 Jul;24:23-9. doi: 10.1016/j.ijid.2014.01.022. Epub 2014 Mar 7. Int J Infect Dis. 2014. PMID: 24614137
-
Effect of copper-impregnated composite bed linens and patient gowns on healthcare-associated infection rates in six hospitals.J Hosp Infect. 2018 Nov;100(3):e130-e134. doi: 10.1016/j.jhin.2018.05.013. Epub 2018 May 24. J Hosp Infect. 2018. PMID: 29803808
-
Reduction of health care-associated infection indicators by copper oxide-impregnated textiles: Crossover, double-blind controlled study in chronic ventilator-dependent patients.Am J Infect Control. 2017 Apr 1;45(4):401-403. doi: 10.1016/j.ajic.2016.11.022. Epub 2016 Dec 26. Am J Infect Control. 2017. PMID: 28034536 Clinical Trial.
-
Brass Alloys: Copper-Bottomed Solutions against Hospital-Acquired Infections?Antibiotics (Basel). 2021 Mar 10;10(3):286. doi: 10.3390/antibiotics10030286. Antibiotics (Basel). 2021. PMID: 33801855 Free PMC article. Review.
-
Hygienic relevance and risk assessment of antimicrobial-impregnated textiles.Curr Probl Dermatol. 2006;33:78-109. doi: 10.1159/000093938. Curr Probl Dermatol. 2006. PMID: 16766883 Review.
Cited by
-
Re-evaluation of the existing health-based guidance values for copper and exposure assessment from all sources.EFSA J. 2023 Jan 17;21(1):e07728. doi: 10.2903/j.efsa.2023.7728. eCollection 2023 Jan. EFSA J. 2023. PMID: 36694841 Free PMC article.
-
Mechanism and Efficacy of Cu2O-Treated Fabric.Antibiotics (Basel). 2022 Nov 16;11(11):1633. doi: 10.3390/antibiotics11111633. Antibiotics (Basel). 2022. PMID: 36421277 Free PMC article.
-
Potent environmental-friendly virucidal medical textiles against coronavirus to combat infections during the COVID-19 pandemic.J Ind Text. 2022 Jun;51(4 Suppl):6996S-7013S. doi: 10.1177/15280837221094649. J Ind Text. 2022. PMID: 38603065 Free PMC article.
-
Preparation of Highly Stable and Cost-Efficient Antiviral Materials for Reducing Infections and Avoiding the Transmission of Viruses such as SARS-CoV-2.ACS Appl Mater Interfaces. 2023 May 10;15(18):22580-22589. doi: 10.1021/acsami.3c03357. Epub 2023 Apr 28. ACS Appl Mater Interfaces. 2023. PMID: 37116104 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases